>
Disorders
>
Mental or Behavioral Dysfunction
>
Schizophrenia, Childhood
Schizophrenia, Childhood
Schizophrenia, Childhood: A complex neurodevelopmental disorder that can manifest in early childhood, characterized by hallucinations, delusions, disorganized speech and behavior, and impaired cognitive functioning.
Early onset schizophrenia is rare but can have severe implications for a child's social, emotional, and academic development.
Understanding the latest research on effective treatments and interventions is crucial for supporting children and their families.
PubCompare.ai's AI-driven platform can help researchers and clinicians easily locate and compare the most cutting-edge protocols to optimize care and improve outcomes for this vulnerable population.
Early onset schizophrenia is rare but can have severe implications for a child's social, emotional, and academic development.
Understanding the latest research on effective treatments and interventions is crucial for supporting children and their families.
PubCompare.ai's AI-driven platform can help researchers and clinicians easily locate and compare the most cutting-edge protocols to optimize care and improve outcomes for this vulnerable population.
Most cited protocols related to «Schizophrenia, Childhood»
Adolescent
Adult
Anger
Arousal
Child
Diagnosis
Feelings
Friend
Interviewers
Legal Guardians
Marshes
Mental Disorders
Mood Disorders
Patients
Population Group
Post-Traumatic Stress Disorder
Sadness
Schizophrenia, Childhood
Survivors
Wounds and Injuries
Biological Assay
CTNNB1 protein, human
DAPI
Embryoid Bodies
Episomes
Family Member
Fibroblasts
Homo sapiens
Immunocytoadherence
Induced Pluripotent Stem Cells
N-Cadherins
Nervousness
Protein, Nestin
Schizophrenia, Childhood
Sendai virus
Skin
Tissue Donors
Adult
Alloys
Child
Chronotype
Creativity
Cyclothymic Disorder
Depressive Symptoms
Diagnosis
Disorder, Attention Deficit-Hyperactivity
Disruptive Behavior Disorder
Epistropheus
Mania
Manic Episode
Mood
Mood Disorders
Parent
Population Group
Psychiatrist
Psychologist
Psychometrics
Sadness
Satisfaction
Schizophrenia, Childhood
Sound
Student
Syndrome
Temperament
Unipolar Depression
Youth
The SDQ has been translated into many languages including Persian under supervision of Goodman in England which is available through the SDQ homepage. The Persian version of the SDQ was used in this study.
K-SADS-PL is capable of generating 32 DSM-III-R and DSM-IV Axis I child and adolescent psychiatric disorders. Diagnoses are made as definite, probable (equal to or greater than 75% of symptom criteria met), or not present. The different components of the K-SADS-PL are described comprehensively in Kauf-man's and Ambrosini's articles.9,10 The K-SADS-PL-P was validated by Shahrivar et al in Iran19 and its specificity was more than %81 and the sensitivities for most major diagnoses were between %75 and %100. The kappa agreement for most diagnoses was higher than 0.4 and the test-retest reliability was between 0.38 and 0.87.
Adolescent
Child
Diagnosis
Diagnosis, Psychiatric
Epistropheus
Hypersensitivity
Mental Disorders
Mood Disorders
Parent
Potassium
Problem Behavior
Psychometrics
Sadness
Schizophrenia, Childhood
Supervision
Youth
Adolescent
Adult
Agoraphobia
Anorexia Nervosa
Anxiety Disorders
Behavior Disorders
Bipolar Disorder
Bipolar Disorder Type 2
Bulimia Nervosa
Conduct Disorder
Diagnosis
Disorder, Attention Deficit-Hyperactivity
Drug Abuse
Drug Dependence
Dysthymic Disorder
Eating Disorders
Ethanol
Fear of disease
Feeding Behaviors
Major Depressive Disorder
Mental Recall
Mood Disorders
Oppositional Defiant Disorder
Panic Disorder
Parent
Phobia, Social
Phobia, Specific
Post-Traumatic Stress Disorder
Sadness
Schizophrenia, Childhood
Separation Anxiety Disorder
Most recents protocols related to «Schizophrenia, Childhood»
Twenty-five measures were included (19 in Analysis 1), as shown in Table 3 . These included number of child psychopathology symptoms (five measures), as well as measures of child exposure to criminal and traumatic events, bullying (two measures), emotion comprehension (three measures) and MacArthur Story Stem Battery (MSSB, [24 ]) assessed children’s representations of their parents and their emotions (eight measures).
![]()
Furthermore, for Analysis 2, maternal report on internalizing and externalizing symptoms in children and four measures concerned with child temperament were added. All measures were validated and possess good to very good psychometrics (Tables 2 and 3 ).
Measures of child outcome dataset at Phase 2.
Measure | Description |
---|---|
ADHD symptoms | Number of ADHD symptoms Child symptoms originally reported by child and judged by clinician in accordance with DSM-V [64 ] |
Behavioral disorders symptoms | Combined number of child symptoms originally reported by child and judged by clinician of oppositional defiant disorder and conduct disorders symptoms in accordance with DSM-V [64 ] |
Depression symptoms | Number of depression symptoms Child symptoms originally reported by child and judged by clinician in accordance with DSM-V [64 ]. |
Anxiety disorders symptoms | Combined number of child symptoms originally reported by child and judged by clinician for generalized anxiety disorder and separation anxiety disorder in accordance with DSM-V [64 ]. |
PTSD symptoms | Number of child PTSD symptoms originally reported by child and judged by clinician in accordance with DSM-5 [64 ]. |
Bullying (perpetration) | Experiences of bullying, measured with the school life survey [66 ] |
Bullying: victimization | Experiences of being the victim of bullying, measured with the school life survey [66 ] |
Emotion comprehension: external emotions understanding | Test of emotion comprehension [69 ], subscale to measure understanding of facial emotions and external causes of emotion |
Emotion comprehension: mental understanding | Test of emotion comprehension [69 ], subscale to measure understanding of belief-based emotions, and possibility of hidden emotions |
Emotion comprehension: reflective capacities | Test of emotion comprehension [69 ], subscale to measure understanding of mixed emotions, emotion regulation, and self-reflection |
VEX Total physical and nonphysical | Reported exposure to violence and criminal activity according to the clinician-administered Violent Experiences Scale (VEX-R) [72 ]. Cronbach’s alpha (English version): between 0.72 and 0.86 [72 ] |
MacArthur: avoidant strategies | Number of behaviors and strategies by child that keep a story from moving forward [65 ] |
MacArthur: dissociative strategies | Number of dissociative behaviors by child during stories [73 (link)] |
MacArthur: Negative Parent: ineffectual | Child represents parents as ineffectual to address story stem challenges [65 ] |
MacArthur: Negative Parent: harsh | Child represents parents as harsh as they address story challenges [65 ] |
MacArthur: Negative story endings | Number of stories that have emotionally negative endings [65 ] |
MacArthur: Aggression overall sum | Overall sum of aggressions incorporated in stories [65 ] |
MacArthur: Atypical negative | Percent stories with atypical, often bizarre, representation with negative connotation [65 ] |
MacArthur: Danger | Sum of diverse danger situations child includes in stories [65 ] |
CBCL internalizing | Internalizing symptoms according to the child Behavior Checklist [67 , 68 (link)] |
CBCL: Externalizing symptoms | Externalizing symptoms according to the Child Behavior Checklist. |
School Life: temperament: negative reactivity | Negative reactivity, i.e.,strong reactions emotional/behavioral reactions to experiencing negative events as measured in the SATI [70 ]. Cronbach’s alpha (English version) >0.89 [71 (link)] |
School Life: Temperament: Task Persistence | Task persistence, i.e., Failure to persist or self-direct with tasks and chores, as measured by the SATI. Cronbach’s alpha (English version) >0.89 [71 (link)] |
School Life: Temperament: approach/withdrawal | Tendency to be shy, withdraw or not approach others as measured by SATI. Cronbach’s alpha (English version) >0.84 [71 (link)] |
School Life: Temperament: Activity | High and potentially hyper or impulsive activity as measured by the SATI. Cronbach’s alpha (English version) >0.80 [71 (link)] |
Abbreviations: ADHD, attention deficit hyperactivity disorder; CBCL, Child Behavior Checklist; K-SADS, Schedule for Affective Disorders and Schizophrenia for School-aged Children; MSSB, MacArthur Story Stem Battery; PTSD, posttraumatic stress disorder; SATI, School-Age Temperament Inventory; VEX-R, Violence Exposure Scale—Revised.
As reported by the mother, only part of Analysis 2, but not of Analysis 1 analysis.
Anxiety Disorders
Behavioral Symptoms
Behavior Disorders
Child
Conduct Disorder
Criminals
Depressive Symptoms
Disorder, Attention Deficit-Hyperactivity
Emotional Regulation
Emotions
Face
Impulsive Behavior
Mood Disorders
Mothers
Oppositional Defiant Disorder
Parent
Physical Examination
Post-Traumatic Stress Disorder
Psychometrics
Sadness
Schizophrenia, Childhood
Separation Anxiety Disorder
Stem, Plant
Temperament
Caregivers will be interviewed using the Kiddie-Schedule for Affective Disorders and Schizophrenia-Early Childhood (K-SADS-EC) which is administered to assess the child’s psychiatric symptoms and assign DSM-5 diagnoses along with the Preschool Age Psychiatric Assessment (PAPA), a reliable measure of Axis I disorders (and severity) in preschool children, (Egger et al., 1999; Egger et al., 2006) [18 , 19 (link)]. Children’s Global Assessment Scale (CGAS) is completed by the clinician rater to measure children’s global level of impairment. Parenting Stress Index (PSI) is used to measure the magnitude of stress within the parent–child dyad via caregiver report. Coping with children’s negative emotions (CCNES) is used to assess parental coping styles and strategies in response to children’s expression of negative emotions via caregiver report. To capture a wider range of problematic behaviors, this study uses the Child Behavior Checklist (CBCL). Preschool Feelings Checklist (PFC) is used to quickly screen for the presence of any symptoms of depression in our population. The Pediatric Sleep Questionnaire (PSQ) is used to examine sleep behavior in young children. Trauma Symptom Checklist for Young Children (TSCYC) is used for the assessment of trauma-related symptoms in children ages 3–12. Finally, the Early Childhood Screening Assessment (ECSA) is used to identify very young children (1½–5 years old) who need further emotional or behavioral assessment.
Children and parents (one primary caregiver) who qualify and agree to participate in the study are given vivosmart4 smartwatches during their screening/baseline assessment visit. Two external service providers are used for aggregating Garmin-collected smartwatch data (Fitabase, cloud-based product of Small Steps Labs LLC) and to deliver real-time alerts for parents and collect daily/weekly behavioral functioning of study’s children (mEMA: mobile Ecological Momentary Assessment, a mobile application product of Ilumivu). Deidentified subject identifiers (IDs) are used to create accounts for Fitabase and mEMA, thereby no protected health information (PHI) of the patient is made available to any external data aggregation or alert service providers. Data is collected and stored throughout the study which is then analyzed at study closure. Data from Garmin vivosmart4 smartwatches are automatically synced to Garmin Connect via participant’s smart device (e.g., smartphone, tablets) and to Ilumivu’s mEMA smartphone app. Each update on Garmin Connect updates the data in Fitabase as well. Ilumivu’s mEMA app, available on iOS and Android app stores, serves to trigger assessments in an attempt to foster parenting practices based on child’s physiology. Optional blood tests (only if patients and primary caregivers upon providing consent) are collected for exploratory work and ongoing collaborations in our local lab.
Children and parents (one primary caregiver) who qualify and agree to participate in the study are given vivosmart4 smartwatches during their screening/baseline assessment visit. Two external service providers are used for aggregating Garmin-collected smartwatch data (Fitabase, cloud-based product of Small Steps Labs LLC) and to deliver real-time alerts for parents and collect daily/weekly behavioral functioning of study’s children (mEMA: mobile Ecological Momentary Assessment, a mobile application product of Ilumivu). Deidentified subject identifiers (IDs) are used to create accounts for Fitabase and mEMA, thereby no protected health information (PHI) of the patient is made available to any external data aggregation or alert service providers. Data is collected and stored throughout the study which is then analyzed at study closure. Data from Garmin vivosmart4 smartwatches are automatically synced to Garmin Connect via participant’s smart device (e.g., smartphone, tablets) and to Ilumivu’s mEMA smartphone app. Each update on Garmin Connect updates the data in Fitabase as well. Ilumivu’s mEMA app, available on iOS and Android app stores, serves to trigger assessments in an attempt to foster parenting practices based on child’s physiology. Optional blood tests (only if patients and primary caregivers upon providing consent) are collected for exploratory work and ongoing collaborations in our local lab.
Full text: Click here
Child
Child, Preschool
Depressive Symptoms
Diagnosis, Psychiatric
Ecological Momentary Assessment
Emotions
Epistropheus
Feelings
Hematologic Tests
Medical Devices
Mood Disorders
Parent
Patients
physiology
Precipitating Factors
Schizophrenia, Childhood
Sleep
Symptom Assessment
Wounds and Injuries
Research measures were included as part of each patient’s standard clinical assessment and took place after referral and before potentially further assessment or treatment.
Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime Version (K-SADS-PL-5) [34 ] was used to determine the psychiatric diagnoses. K-SADS-PL-5 is a validated semi-structured diagnostic interview corresponding with DSM-5 diagnoses frequently applied in research and clinical practice [35 (link)]. Thirteen clinical psychologists and final year clinical psychology students administered the Norwegian version of K-SADS-PL-5 with parents. Reliability was established in three ways: first, interviewers were trained in the administration of K-SADS-PL-5 before they contributed to the data collection. Secondly, cases were discussed in conference with other clinicians. Thirdly, 9% (n = 19) of the interviews were scored independently by two clinicians, demonstrating a substantial agreement between the interviewers’ diagnostic evaluations (Cohen’s к = 0.80).
Child Behavior Check List (CBCL) [36 ], was completed by parents. Irritability was measured using the CBCL Irritability scale that consists of three CBCL items: (I) temper tantrums or hot temper, (II) stubborn, sullen, or irritable, and (III) sudden changes in mood or feelings. Items are rated on a 3-points Likert-scale (not true, sometimes true, often true) with a range of 0 (none) to 6 (high). Raw scores were used in the statistical analyses.
Behavior Rating Inventory of Executive Function 2nd edition (BRIEF-2) [25 ] is designed to measure children’s EF in social and behavioral contexts. Parents rated the frequency of behavior on a 3-point Likert-scale (never, sometimes, often). The BRIEF-2 includes the following scales: Inhibit (also referred to as Inhibition), Self-Monitor, Shift (also referred to as Cognitive Flexibility), Emotion Control, Initiate, Working Memory, Plan/Organize, Task-Monitor, and Organization of Materials. Raw scores were converted to T-scores based on validated norms [25 ]. Raw scores were used in the statistical analyses and T-scores were used to examine whether the group’s scores were within normal or clinical range compared to standardized norm values. T-scores ≥ 65 is regarded as in the clinical range [25 ], indicative of clear problems. For participants with < 5% missing item response, the median value for all participants (n = 188) was imputed.
NEPSY Second-edition (NEPSY-2) [24 ] is a performance-based neuropsychological assessment tool. Participants completed three subtests: (1) Design Fluency (for children between 5 and 12 years) assessing behavioral productivity and the child’s ability to generate unique designs by connecting five dots, presented in a structured and random way, (2) Inhibition measuring the ability to inhibit automatic responses (5–16 years) and to switch between response styles (7–16 years), and (3) Word List Interference (7–16 years) assessing verbal working memory. Raw scores were transformed to standardized scaled scores by Pearson’s NEPSY-2 machine-based scoring-tool. The scaled scores were used in the statistical analyses, and to examine whether the group’s scores were within normal range compared to standardized norm values. Scaled scores < 8 are indicative of clinical scores, clearly below normal levels.
Full Scale IQ (FSIQ) or General Ability Index (GAI) was estimated using the Wechsler Intelligence Scale for Children, fifth edition [37 ] if the healthcare professional responsible for the child’s treatment found it necessary as part of the child’s clinical assessment.
Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime Version (K-SADS-PL-5) [34 ] was used to determine the psychiatric diagnoses. K-SADS-PL-5 is a validated semi-structured diagnostic interview corresponding with DSM-5 diagnoses frequently applied in research and clinical practice [35 (link)]. Thirteen clinical psychologists and final year clinical psychology students administered the Norwegian version of K-SADS-PL-5 with parents. Reliability was established in three ways: first, interviewers were trained in the administration of K-SADS-PL-5 before they contributed to the data collection. Secondly, cases were discussed in conference with other clinicians. Thirdly, 9% (n = 19) of the interviews were scored independently by two clinicians, demonstrating a substantial agreement between the interviewers’ diagnostic evaluations (Cohen’s к = 0.80).
Child Behavior Check List (CBCL) [36 ], was completed by parents. Irritability was measured using the CBCL Irritability scale that consists of three CBCL items: (I) temper tantrums or hot temper, (II) stubborn, sullen, or irritable, and (III) sudden changes in mood or feelings. Items are rated on a 3-points Likert-scale (not true, sometimes true, often true) with a range of 0 (none) to 6 (high). Raw scores were used in the statistical analyses.
Behavior Rating Inventory of Executive Function 2nd edition (BRIEF-2) [25 ] is designed to measure children’s EF in social and behavioral contexts. Parents rated the frequency of behavior on a 3-point Likert-scale (never, sometimes, often). The BRIEF-2 includes the following scales: Inhibit (also referred to as Inhibition), Self-Monitor, Shift (also referred to as Cognitive Flexibility), Emotion Control, Initiate, Working Memory, Plan/Organize, Task-Monitor, and Organization of Materials. Raw scores were converted to T-scores based on validated norms [25 ]. Raw scores were used in the statistical analyses and T-scores were used to examine whether the group’s scores were within normal or clinical range compared to standardized norm values. T-scores ≥ 65 is regarded as in the clinical range [25 ], indicative of clear problems. For participants with < 5% missing item response, the median value for all participants (n = 188) was imputed.
NEPSY Second-edition (NEPSY-2) [24 ] is a performance-based neuropsychological assessment tool. Participants completed three subtests: (1) Design Fluency (for children between 5 and 12 years) assessing behavioral productivity and the child’s ability to generate unique designs by connecting five dots, presented in a structured and random way, (2) Inhibition measuring the ability to inhibit automatic responses (5–16 years) and to switch between response styles (7–16 years), and (3) Word List Interference (7–16 years) assessing verbal working memory. Raw scores were transformed to standardized scaled scores by Pearson’s NEPSY-2 machine-based scoring-tool. The scaled scores were used in the statistical analyses, and to examine whether the group’s scores were within normal range compared to standardized norm values. Scaled scores < 8 are indicative of clinical scores, clearly below normal levels.
Full Scale IQ (FSIQ) or General Ability Index (GAI) was estimated using the Wechsler Intelligence Scale for Children, fifth edition [37 ] if the healthcare professional responsible for the child’s treatment found it necessary as part of the child’s clinical assessment.
Full text: Click here
Cardiac Arrest
Child
Cognition
Conferences
Diagnosis
Diagnosis, Psychiatric
Emotions
Executive Function
Feelings
Health Care Professionals
Interviewers
Memory, Short-Term
Mood
Mood Disorders
Neuropsychological Tests
Parent
Patients
Psychological Inhibition
Sadness
Schizophrenia, Childhood
Student
Full text: Click here
Anhedonia
Apathy
Child
Child, Preschool
Depressive Symptoms
Diagnosis, Psychiatric
Disorder, Depressive
Major Depressive Disorder
Mood Disorders
Nervous System Disorder
Parent
Patients
Physical Examination
Psychiatrist
Psychological Inhibition
Schizophrenia, Childhood
Participants were recruited from outpatient clinics at Shenzhen Children’s Hospital. From previous literature review [9 (link), 16 (link)] and preliminary user test data, we expected that the drop-out rate of AET would be higher than that of GET. Therefore, eligible participants were allocated in a 1.2:1 ratio to receive ADHD executive function training or a general executive function training (Fig. 1 ).![]()
ADHD children aged 6 to 12 years old were diagnosed by child psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the diagnoses were confirmed using Kiddie Schedule for Affective Disorders and Schizophrenia for School-Aged Children Present-Lifetime version (K-SADS-PL parent version) [24 (link)]. Other eligibility criteria include IQ of 80 or above on the Chinese version of Wechsler Intelligence Scale (fourth edition) for Children (WISC-IV) [40 ] and ability to understand the tasks in the training. Exclusion criteria were as follows: (1) serious medical conditions or neuropsychiatric diseases such as epilepsy and mental retardation; (2) diagnosis of tic disorders; (3) abnormalities in other medical tests that investigators consider to be clinically significant; (4) initiating or terminating behavioral therapy within the prior three months; (5) use of psychotropic medication in the prior month; and (6) history of gaming addiction. Written informed consent was obtained from all parents or guardians, as well as from participants themselves if they were 8 years old or older before baseline screening. Parents and children were informed that they would be assigned one of two cognitive trainings, and that this study aimed to compare the effect of these trainings on cognitive development in children with ADHD. Participants were unaware of the difference in training between the two groups.
Flow diagram of the clinical trial
Full text: Click here
Addictive Behavior
Behavior Therapy
Child
Child Development
Chinese
Cognition
Cognitive Training
Congenital Abnormality
Diagnosis
Disorder, Attention Deficit-Hyperactivity
Eligibility Determination
Epilepsy
Executive Function
Intellectual Disability
Legal Guardians
Mood Disorders
Parent
Psychiatrist
Psychotropic Drugs
Sadness
Schizophrenia, Childhood
Tic Disorder
Wechsler Scales
Top products related to «Schizophrenia, Childhood»
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in United States
SPSS version 16.0 for Windows is a software package designed for statistical analysis. It provides a comprehensive set of tools for data management, analysis, and presentation. The software is intended to assist users in conducting various statistical procedures, including descriptive statistics, regression analysis, and hypothesis testing.
Sourced in United States, Germany, United Kingdom, Canada, France, Japan, China, Australia, Italy, Switzerland, Belgium, Spain, Sweden, Portugal, Israel, Netherlands, Denmark, Macao, Norway, Brazil, Ireland, Gabon, New Zealand, Austria
Sodium pyruvate is a chemical compound commonly used in cell culture media. It serves as an energy source for cells and is involved in various metabolic processes. Sodium pyruvate is a key intermediate in the citric acid cycle, which is the central pathway for cellular respiration and energy production.
More about "Schizophrenia, Childhood"
Schizophrenia in Children, Childhood-Onset Schizophrenia, Early-Onset Schizophrenia, Pediatric Schizophrenia, Juvenile Schizophrenia.
Schizophrenia is a complex neurodevelopmental disorder that can manifest in the early stages of childhood, characterized by hallucinations, delusions, disorganized speech and behavior, and impaired cognitive functioning.
While rare, this form of schizophrenia can have severe implications for a child's social, emotional, and academic development.
Understanding the latest research on effective treatments and interventions is crucial for supporting children with schizophrenia and their families.
Penicillin/streptomycin, a common antibiotic combination, and SPSS version 16.0 for Windows, a statistical analysis software, may play a role in understanding and managing this condition.
Sodium pyruvate, a metabolic compound, has also been studied in the context of schizophrenia, as it may have implications for the disorder's underlying neurological mechanisms.
By leveraging the insights gained from these related topics, researchers and clinicians can optimize care and improve outcomes for this vulnerable population.
PubCompare.ai's cutting-edge, AI-driven platform can help you easily locate and compare the most up-to-date protocols from literature, pre-prints, and patents, empowering your research and uncovering the optimal path forward.
Experience seamless protocol discovery and analysis with our intelligent tools and uncover the latest breakthroughs in the treatment and management of childhood-onset schizophrenia.
Schizophrenia is a complex neurodevelopmental disorder that can manifest in the early stages of childhood, characterized by hallucinations, delusions, disorganized speech and behavior, and impaired cognitive functioning.
While rare, this form of schizophrenia can have severe implications for a child's social, emotional, and academic development.
Understanding the latest research on effective treatments and interventions is crucial for supporting children with schizophrenia and their families.
Penicillin/streptomycin, a common antibiotic combination, and SPSS version 16.0 for Windows, a statistical analysis software, may play a role in understanding and managing this condition.
Sodium pyruvate, a metabolic compound, has also been studied in the context of schizophrenia, as it may have implications for the disorder's underlying neurological mechanisms.
By leveraging the insights gained from these related topics, researchers and clinicians can optimize care and improve outcomes for this vulnerable population.
PubCompare.ai's cutting-edge, AI-driven platform can help you easily locate and compare the most up-to-date protocols from literature, pre-prints, and patents, empowering your research and uncovering the optimal path forward.
Experience seamless protocol discovery and analysis with our intelligent tools and uncover the latest breakthroughs in the treatment and management of childhood-onset schizophrenia.